Literature DB >> 5912681

On the mechanism of the anti-inflammatory activity of hexadimethrine bromide.

D N Kellett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5912681      PMCID: PMC1510635          DOI: 10.1111/j.1476-5381.1966.tb01914.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


× No keyword cloud information.
  6 in total

1.  EFFECT OF ANTI-INFLAMMATORY AGENTS ON CAPILLARY PERMEABILITY AND OEDEMA FORMATION.

Authors:  D M BROWN; R D ROBSON
Journal:  Nature       Date:  1964-05-23       Impact factor: 49.962

2.  A NEW ADRENERGIC BETARECEPTOR ANTAGONIST.

Authors:  J W BLACK; A F CROWTHER; R G SHANKS; L H SMITH; A C DORNHORST
Journal:  Lancet       Date:  1964-05-16       Impact factor: 79.321

3.  ON THE ANTI-INFLAMMATORY ACTIVITY OF PROTAMINE SULPHATE AND OF HEXADIMETHRINE BROMIDE, INHIBITORS OF PLASMA KININ FORMATION.

Authors:  D N KELLETT
Journal:  Br J Pharmacol Chemother       Date:  1965-06

4.  Anti-heparin agents as inhibitors of plasma kinin formation.

Authors:  D A ARMSTRONG; J W STEWART
Journal:  Nature       Date:  1962-05-19       Impact factor: 49.962

5.  Active polypeptides derived from plasma proteins.

Authors:  G P LEWIS
Journal:  Physiol Rev       Date:  1960-10       Impact factor: 37.312

6.  EFFECT OF HEXADIMETHRINE BROMIDE ON PLASMA KININ FORMATION, HYDROLYSIS OF P-TOSYL-L-ARGININE METHYL ESTER AND FIBRINOLYSIS.

Authors:  V EISEN
Journal:  Br J Pharmacol Chemother       Date:  1964-02
  6 in total
  2 in total

1.  On the involvement of the kinin-system in anaphylactic shock of guinea pigs.

Authors:  G Garbe; R Frank; K D Friedberg
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

2.  Constitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrity.

Authors:  Martha M Monick; Linda S Powers; Christopher W Barrett; Sara Hinde; Alix Ashare; Dayna J Groskreutz; Toru Nyunoya; Mitchell Coleman; Douglas R Spitz; Gary W Hunninghake
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.